BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31068788)

  • 21. Cerebellar Development and Circuit Maturation: A Common Framework for Spinocerebellar Ataxias.
    Binda F; Pernaci C; Saxena S
    Front Neurosci; 2020; 14():293. PubMed ID: 32300292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spinocerebellar ataxias.
    Gilman S
    Clin Neuropharmacol; 2000; 23(6):296-303. PubMed ID: 11575863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroradiological Findings in the Spinocerebellar Ataxias.
    Meira AT; Arruda WO; Ono SE; Neto AC; Raskin S; Camargo CHF; Teive HAG
    Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31632837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinocerebellar ataxia type 4 (SCA4): Initial pathoanatomical study reveals widespread cerebellar and brainstem degeneration.
    Hellenbroich Y; Gierga K; Reusche E; Schwinger E; Deller T; de Vos RA; Zühlke C; Rüb U
    J Neural Transm (Vienna); 2006 Jul; 113(7):829-43. PubMed ID: 16362839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual oculomotor abnormalities and vestibulo‑ocular reflex dynamics in polyglutamine spinocerebellar ataxias (Review).
    Peng Y; Tu Q; Han Y; Wan C; Gao L
    Exp Ther Med; 2023 Jul; 26(1):358. PubMed ID: 37324515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Keeping Our Calcium in Balance to Maintain Our Balance.
    Mark MD; Schwitalla JC; Groemmke M; Herlitze S
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1040-1050. PubMed ID: 27392710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches.
    Velázquez-Pérez LC; Rodríguez-Labrada R; Fernandez-Ruiz J
    Front Neurol; 2017; 8():472. PubMed ID: 28955296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Movement disorders in spinocerebellar ataxias.
    van Gaalen J; Giunti P; van de Warrenburg BP
    Mov Disord; 2011 Apr; 26(5):792-800. PubMed ID: 21370272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synapses in the hereditary ataxias.
    Koeppen AH; Dickson AC; Lamarche JB; Robitaille Y
    J Neuropathol Exp Neurol; 1999 Jul; 58(7):748-64. PubMed ID: 10411345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genes implicated in the pathogenesis of spinocerebellar ataxias.
    Wüllner U
    Drugs Today (Barc); 2003 Dec; 39(12):927-37. PubMed ID: 14747838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice.
    Palomo-Garo C; Gómez-Gálvez Y; García C; Fernández-Ruiz J
    Pharmacol Res; 2016 Aug; 110():181-192. PubMed ID: 27063942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development.
    Shimobayashi E; Kapfhammer JP
    Curr Neuropharmacol; 2018 Jan; 16(2):151-159. PubMed ID: 28554312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebellar ataxias.
    Manto M; Marmolino D
    Curr Opin Neurol; 2009 Aug; 22(4):419-29. PubMed ID: 19421057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion.
    Niewiadomska-Cimicka A; Hache A; Trottier Y
    Front Neurosci; 2020; 14():571. PubMed ID: 32581696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular pathogenesis of spinocerebellar ataxias.
    Dueñas AM; Goold R; Giunti P
    Brain; 2006 Jun; 129(Pt 6):1357-70. PubMed ID: 16613893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The endocannabinoid system in Huntington's disease.
    Pazos MR; Sagredo O; Fernández-Ruiz J
    Curr Pharm Des; 2008; 14(23):2317-25. PubMed ID: 18781982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroimaging Applications in Chronic Ataxias.
    Mascalchi M; Vella A
    Int Rev Neurobiol; 2018; 143():109-162. PubMed ID: 30473193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translating cerebellar Purkinje neuron physiology to progress in dominantly inherited ataxia.
    Chopra R; Shakkottai VG
    Future Neurol; 2014 Mar; 9(2):187-196. PubMed ID: 25221437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
    Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
    Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterotopic Purkinje Cells: a Comparative Postmortem Study of Essential Tremor and Spinocerebellar Ataxias 1, 2, 3, and 6.
    Louis ED; Kuo SH; Tate WJ; Kelly GC; Gutierrez J; Cortes EP; Vonsattel JG; Faust PL
    Cerebellum; 2018 Apr; 17(2):104-110. PubMed ID: 28791574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.